Nicoleta C. Voian

Public Health and Preventive Medicine | Medical Genetics

4805 Northeast Glisan Street
Suite 11N-3
Portland, OR 97213

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 08, 2025

Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 23, 2024

Response to Stern.

Response to Stern.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: November 08, 2023

Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: February 14, 2023

Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: March 04, 2021

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: January 02, 2017

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 07, 2016

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 06, 2014

Decision making after BRCA genetic testing. Down the road of transition.

Decision making after BRCA genetic testing. Down the road of transition.

Journal: Clinical journal of oncology nursing

Published: May 29, 2014

Pyrimidine base damage is increased in women with BRCA mutations.

Pyrimidine base damage is increased in women with BRCA mutations.

Journal: Cancer letters

Published: December 20, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026